Premium
Bupropion‐induced somnambulism
Author(s) -
KHAZAAL YASSER,
KRENZ SONIA,
ZULLINO DANIELE FABIO
Publication year - 2003
Publication title -
addiction biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.445
H-Index - 78
eISSN - 1369-1600
pISSN - 1355-6215
DOI - 10.1080/13556210310001602284
Subject(s) - bupropion , sleepwalking , amnesia , monoaminergic , nicotine , dopaminergic , psychology , medicine , evening , psychiatry , smoking cessation , dopamine , receptor , sleep disorder , cognition , serotonin , physics , pathology , astronomy
Whereas there are some case reports of bupropion‐induced vivid dreaming and nightmares, until now it has not been associated with somnambulism. A case is reported of a patient treated with bupropion as a smoking cessation medication, who developed somnambulism during nicotine withdrawal. Furthermore, the sleepwalking episodes were associated with eating behaviour. Amnesia was reported for all episodes. As, on one hand, bupropion is a noradrenergic and dopaminergic drug and nicotine withdrawal, on the other hand, is associated with alterations in monoaminergic functions, an interaction at the level of these neurotransmitters is suggested as the underlying mechanism.